6760-43-6 Usage
Uses
Used in Pharmaceutical Research and Drug Development:
(1s,5s)-9-azabicyclo[3.3.1]nonane hydrochloride is used as a research compound for investigating its potential therapeutic effects on neurological disorders and psychiatric diseases. Its unique structure allows it to interact with receptors and ligands in the central nervous system, providing insights into the development of new treatments for these conditions.
Used in Medicinal Chemistry:
In the field of medicinal chemistry, (1s,5s)-9-azabicyclo[3.3.1]nonane hydrochloride is used as a lead compound for the design and synthesis of new drugs. Its pharmacological properties and interactions with the central nervous system make it a valuable template for creating novel therapeutic agents.
Used in Pharmacology:
(1s,5s)-9-azabicyclo[3.3.1]nonane hydrochloride is utilized in pharmacological studies to understand its mechanism of action and potential side effects. This knowledge is crucial for optimizing its therapeutic potential and ensuring its safety and efficacy in clinical applications.
Used in Drug Discovery:
As a compound with potential therapeutic benefits, (1s,5s)-9-azabicyclo[3.3.1]nonane hydrochloride is used in drug discovery processes to identify new drug candidates. Researchers and scientists are exploring its properties and interactions to develop innovative treatments for various medical conditions.
Check Digit Verification of cas no
The CAS Registry Mumber 6760-43-6 includes 7 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 4 digits, 6,7,6 and 0 respectively; the second part has 2 digits, 4 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 6760-43:
(6*6)+(5*7)+(4*6)+(3*0)+(2*4)+(1*3)=106
106 % 10 = 6
So 6760-43-6 is a valid CAS Registry Number.
6760-43-6Relevant academic research and scientific papers
Estrogen receptor ligands. Part 7: Dihydrobenzoxathiin SERAMs with bicyclic amine side chains
Blizzard, Timothy A.,DiNinno, Frank,Morgan II, Jerry D.,Chen, Helen Y.,Wu, Jane Y.,Gude, Candido,Kim, Seongkon,Chan, Wanda,Birzin, Elizabeth T.,Yang, Yi Tien,Pai, Lee-Yuh,Zhang, Zhoupeng,Hayes, Edward C.,DaSilva, Carolyn A.,Tang, Wei,Rohrer, Susan P.,Schaeffer, James M.,Hammond, Milton L.
, p. 3861 - 3864 (2007/10/03)
A series of benzoxathiin SERAMs with bicyclic amine side chains was prepared. Minor modifications in the side chain resulted in significant effects on biological activity, especially in uterine tissue.
